Service profile
Aligos Therapeutics
Biopharmaceutical company developing therapies for chronic hepatitis B, coronaviruses, and nonalcoholic steatohepatitis (NASH) using small molecule and oligonucleotide therapeutic platforms targeting viral replication and liver disease mechanisms.
About
What Aligos Therapeutics is
Biopharmaceutical company developing therapies for chronic hepatitis B, coronaviruses, and nonalcoholic steatohepatitis (NASH) using small molecule and oligonucleotide therapeutic platforms targeting viral replication and liver disease mechanisms.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://aligostherapeutics.com |
| Status coverage | Public status page |
| Founded | 2018 |
| Headquarters | South San Francisco, California, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...